The mechanisms seem more complicated in patients with DTC/+T2DM because the circulating levels of NT-proBNP, NT-proANP, and ST2/IL-33R were higher, while the levels of cTn I were lower than in patients without T2DM. This evidence concerns the gene NPPB and type 2 diabetes mellitus.